Hyderabad, Mar 09: Bondada Group marked International Women’s Day with a special event dedicated to celebrating women’s strength, leadership, and resilience. The occasion was highlighted by an inspiring address from the Chief Guest, Smt. J. Parimala Hana Nutan, IPS, Deputy Inspector General (DIG), CID, Hyderabad, Telangana, who shared powerful insights from her distinguished career in public service.

The certification establishes a formal framework for the responsible development, deployment, and oversight of artificial intelligence systems. Following a comprehensive independent audit, the certification confirms that K&L Gates’ AI program operates with robust controls around accountability, risk management, ethics, transparency, data protection, and regulatory compliance.

This milestone validates that governance principles are embedded across K&L Gates’ AI lifecycle—from evaluation and implementation to ongoing monitoring and improvement. As regulatory scrutiny and client expectations surrounding AI continue to evolve globally, the certification reinforces K&L Gates’ leadership in responsible AI adoption within the legal industry.

“This certification reflects our commitment to combining innovation with accountability,” said Stacy Ackermann, Global Managing Partner of K&L Gates. “Clients are embracing AI to transform their businesses, and they expect their law firms to responsibly do the same. Achieving ISO/IEC 42001:2023 certification demonstrates that we have built a governance framework that prioritizes risk management, transparency, and trust while enabling us to deliver valuable insight and legal services to our clients.”

Harpreet Suri, Chief Technology Officer of K&L Gates, added: “As organizations across industries implement or evaluate AI technologies, they increasingly expect the same discipline and transparency from their legal advisers. Achieving ISO/IEC 42001:2023 certification is a direct result of the dedication and rigor of our technology, security and information governance teams, whose work ensures that AI is deployed responsibly, securely, and in alignment with our professional obligations. This certification enables K&L Gates to provide enhanced confidence in how AI is thoughtfully and responsibly integrated into our client service delivery.”

In 2023, K&L Gates established a cross-disciplinary AI Solutions Group to guide its firmwide AI strategy, advising clients on developing, deploying, and investing in AI technologies. The firm also implemented a comprehensive Generative AI Policy and AI Forward℠ framework that mandates approved platforms, transparency with clients, verification of AI outputs, and mandatory training, all guided by principles of responsible innovation and human-centric excellence.

As an early adopter of generative AI, K&L Gates employs centralized governance to oversee AI deployment across its global platform, ensuring alignment with confidentiality obligations, data-governance requirements, and professional standards. AI enhances legal research, drafting, contract review, due diligence, and discovery through vetted AI platforms including Legora, Vincent, Westlaw Precision AI, Relativity Analytics, CoCounsel, and Microsoft 365 Copilot.

Firmwide adoption is supported by role-specific training with AltaClaro, as its first law firm partner, and Hotshot Legal, emphasizing AI literacy, prompt engineering, and partner supervisory oversight. The firm’s leadership extends beyond internal operations through the K&L Gates Endowment for Ethics and Computational Technologies at Carnegie Mellon University in 2016 and a founding sponsor for the AI Access to Justice Summit. In 2025, K&L Gates was named an “Innovation Icon” by BTI Consulting Group for integrating AI into its global client-service strategy.

Apeejay Stya and Svran Group recently organised the 12^th Indian Obstetrics and Gynaecology (IOG) Dr. Stya Paul Awards 2025-26, carrying forward the noble endeavour to promote cutting-edge research and exemplary medical services in Obstetrics and Gynaecology.

Dr Stya Paul – eminent industrialist, educationist, freedom fighter and philanthropist is the inspiration behind all Apeejay Stya institutions. These awards have been instituted to recognise outstanding articles published in the IOG Journal for Basic & Clinical Research. This highly-anticipated event that has become an annual fixture of the research & medical community pertaining to Obstetrics and Gynaecology all over the country and abroad, was held at New Delhi.

IOG Dr. Stya Paul Awards 2025-26 were given to the authors of Best Papers published in the Journal under three categories: Best Case Report, Best Review Article and Best Original Study. ‘Special Awards’ were given for outstanding contributions of the medical fraternity, under different categories.

The highlight of the event this year was the illuminating Oration Lecture by Dr. Deirdre J Lyell, Dunlevie Endowed Professor of Maternal-Fetal Medicine at Stanford Medicine. She also serves as Chair and Principal Investigator of the California Maternal Quality Care Collaborative. Dr. Lyell brings more than 25 years of clinical, research, leadership and teaching experience in maternal-fetal medicine.

She delivered an insightful address on ‘Placental Dysfunction from Pathophysiology to Clinical Practice’. She shed light on early detection of placental abnormalities, appropriate delivery planning, prevention of unnecessary caesarean sections, and long-term maternal health implications, positioning placental science as key to safer pregnancies and future disease prevention for women. 

Mrs. Sushma Paul Berlia, Chairman, Apeejay Stya and Svran Group, and daughter of Dr. Stya Paul, said, “The IOG awards in the name of my late father Dr. Stya Paul is a reminder that like him, if we try to reach our highest purpose, we would be so much more than we could have ever imagined ourselves to be.”

She said that, “These awards in the name of Dr. Stya Paul are meant to go beyond remembering his illustrious life by cherishing the values he stood for and to take them forward.” She added that through his life journey, Dr. Stya Paul exemplified that against all odds, extra-ordinary heights can be achieved by dreaming with determination, grit and resilience, to attain the grandest version of oneself.

Mr. Nishant Berlia, Dr. Neha Berlia and Mr. Aditya Berlia – Co-owners and Group Directors – Apeejay Stya and Svran Group, are grandchildren of Dr. Stya Paul, who are leading various verticals of the group, under overarching leadership of Mrs. Sushma Paul Berlia. Mr. Nishant Berlia and Dr. Neha Berlia graced the occasion, and Mr. Aditya Berlia, extended his best wishes from abroad.

The Indian Obstetrics & Gynaecology (IOG) Journal commenced in year 2011 as a new specialty publication designed for budding & established authors & researchers in Obstetrics and Gynaecology, by giving them a platform to publish their research. It is published by Apeejay Stya Publishing Pvt. Ltd. and is independent of the publishing house for scientific contents. The IOG journal is indexed in EBSCO, Google Scholar and has also been included in the UGC Care List.

Like every year, the event also proved to be a great networking platform for doctors and researchers wherein they shared their knowledge, experiences and concerns with each other.

Kinaxis® Inc. (“Kinaxis” or the “Company”) (TSX: KXS) today announces that, further to its previously announced intention to maximize the size of its normal course issuer bid (the “NCIB”), it has received approval from the Toronto Stock Exchange (the “TSX”) to amend (the “Amendment”) the NCIB, effective on March 11, 2026 (the “Effective Date”), to increase the maximum number of common shares (the “Shares”) that may be repurchased from 1,403,042, representing 5% of the Company’s issued and outstanding Shares as at October 31, 2025, to 2,799,843, representing 10% of the Company’s “public float” as at October 31, 2025, the maximum amount allowable under the rules of the TSX. No other terms of the NCIB have been amended. The Company has already invested US$54 million under its current NCIB. At the average price paid to date for the Shares under the current NCIB, repurchasing 10% of the Shares would represent an additional investment of approximately US$284 million.

In its February 4, 2026 news release, Kinaxis highlighted the rationale for maximizing the NCIB, with Razat Gaurav, chief executive officer, stating, “There is a fundamental misunderstanding of the opportunities and threats from generative and agentic AI to mission-critical enterprise software, like ours, that solves deeply complex problems and enables highly consequential decisions. As a result, the public markets may not be fully reflecting the underlying value of Kinaxis from time to time. We see value to shareholders in maximizing our ability to buy back Shares under the NCIB structure or other structures that may also be available to Kinaxis. Our substantial moat in industry is built on decades of deep domain knowledge, and our Maestro platform represents the most granular and holistic representation of how underlying supply chains operate. Maestro’s predictions, intelligence and prescriptive decisions are made possible by leveraging a fusion of advanced machine learning, optimization and heuristics. These capabilities are fundamental to supply chain planning and decision making and are enhanced, not replaced, by GenAI, composable agentic AI, and the latest semantic and data architectures to achieve the next generation of supply chain orchestration. We are excited about the possibilities.”

The NCIB, which began on November 12, 2025, and will end no later than November 11, 2026, is being conducted on the open market through the facilities of the TSX and/or alternative Canadian trading systems or by such other means as may be permitted by the applicable securities regulators. Except for block purchases permitted under the rules of the TSX, the number of Shares to be purchased per day under the NCIB will not exceed 14,137, which represents 25% of the average daily trading volume of the Shares on the TSX for the six calendar months ended October 31, 2025 (being 56,549 Shares). Kinaxis previously entered into an automatic share repurchase plan under which its designated broker will repurchase Shares pursuant to the NCIB, and the automatic plan, which will be amended as of the Effective Date to account for the Amendment, will continue to apply to the amended NCIB. The actual number of Shares purchased under the NCIB, including under the automatic plan, the timing of such purchases and the price at which Shares are purchased will depend upon future market conditions and will be determined by management of the Company, subject to applicable law and the rules of the TSX. The automatic plan, which was pre-cleared by the TSX, provides for the potential repurchase of Shares at any time, including when Kinaxis ordinarily would not be active in the market due to it being in a blackout period.

Under the NCIB, to date, Kinaxis has repurchased for cancellation an aggregate of 447,738 Shares (at an average price of C$167.50 per Share).

About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro™, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain – from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Cautionary Note and Forward-Looking Information
This press release contains forward-looking information within the meaning of Canadian securities legislation. Forward-looking information relates to future events or the anticipated performance of Kinaxis and reflects management’s expectations or beliefs regarding such future events. In certain cases, statements that contain forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur” or “be achieved” or the negative of these words or comparable terminology. Forward-looking information in this press release includes statements with respect to the potential future purchases by Kinaxis of Shares pursuant to the NCIB and the benefits of the NCIB. By its very nature forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual performance of Kinaxis to be materially different from any anticipated performance expressed or implied by such forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in the Company’s annual information form dated March 4, 2026 for its fiscal year ended December 31, 2025 and other risks identified in the Company’s filings with Canadian securities regulators, which filings are available on SEDAR+ at https://www.sedarplus.ca.

The risk factors referred to above are not an exhaustive list of the factors that may affect any of the Company’s forward-looking information. Forward-looking information includes statements about the future and is inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations, and opinions of management on the date the statements are made, and the Company does not assume any obligation to update such forward-looking information if circumstances or management’s beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

SOURCE: Kinaxis Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260309385608/en/